A rapid, PCR based test for differential molecular diagnosis of Prader-Willi and Angelman syndromes.

K A Chotai, S J Payne

Kennedy-Galton Centre for Medical and Community Genetics, and St Mark's NHS Trust, Harrow, Middlesex, UK.

Approximately 98% of Prader-Willi syndrome (PWS) and 80% of Angelman syndrome (AS) cases have deletions at a common region in chromosome 15q11-13, uniparental disomy for chromosomes 15 (UPD15), or mutations affecting gene expression in this region. The resulting clinical phenotype (PWS or AS) in each class of mutation depends upon the parent of origin. Both disorders are characterised at the molecular level by abnormal methylation of imprinted genes at 15q11-q13 including the small nuclear ribonucleoprotein N gene (SNRPN). Current diagnostic strategies include high resolution cytogenetics, fluorescence in situ hybridisation (FISH), Southern blot hybridisation, or microsatellite typing. We have developed a novel and rapid diagnostic test for PWS and AS based on differential digestion of expressed (paternally imprinted) SNRPN sequences by the methylation sensitive endonuclease NotI or repressed (maternally imprinted) SNRPN sequences by the methylation requiring nuclease McrBC, followed by PCR amplification of the SNRPN promoter. We have evaluated this test by blinded analysis of 60 characterised DNA samples (20 PWS, 20 AS, and 20 unaffected controls). SNRPN sequences could not be amplified from PWS patient DNA which had been digested with McrBC, nor from AS patient DNA which had been digested with NotI. We were able to make a correct diagnosis of PWS, AS, or unaffected in all 60 samples tested. This novel test is rapid and has a high specificity and sensitivity for deletion and UPD15 cases. These features make this new test suitable as the initial step in a molecular diagnostic strategy for PWS/AS.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Kamalakaran, S., Kendall, J., Zhao, X., Tang, C., Khan, S., Ravi, K., Auletta, T., Riggs, M., Wang, Y., Helland, A., Naume, B., Dimitrova, N., Borresen-Dale, A.-L., Hicks, J., Lucito, R. (2009). Methylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation. Nucleic Acids Res 37: e89-e89 [Abstract] [Full Text]  
• Goldstone, A. P., Holland, A. J., Hauffa, B. P., Hokken-Koelega, A. C., Tauber, M., on behalf of speakers contributors at the Second E, (2008). Recommendations for the Diagnosis and Management of Prader-Willi Syndrome. J. Clin. Endocrinol. Metab. 93: 4183-4197 [Abstract] [Full Text]  
• Ng, Y., Tan, I., Lim, L., Leung, T. (2004). Expression of the Human Myotonic Dystrophy Kinase-related Cdc42-binding Kinase {gamma} Is Regulated by Promoter DNA Methylation and Sp1 Binding. J. Biol. Chem. 279: 34156-34164 [Abstract] [Full Text]  
• Rabinowicz, P. D., Palmer, L. E., May, B. P., Hemann, M. T., Lowe, S. W., McCombie, W. R., Martienssen, R. A. (2003). Genes and Transposons Are Differentially Methylated in Plants, but Not in Mammals. Genome Res 13: 2658-2664 [Abstract] [Full Text]  
• Hoybye, C., Hilding, A., Jacobsson, H., Thoren, M. (2002). Metabolic Profile and Body Composition in Adults with Prader-Willi Syndrome and Severe Obesity. J. Clin. Endocrinol. Metab. 87: 3590-3597 [Abstract] [Full Text]